NuPathe (PATH)
Add to Watchlists Create an Alert
3.17
+0.06 +1.93%
NASDAQ
May 24, 8:00PM
BATS Real time
Currency in USD
NuPathe Book Value Per Share:
-0.1459 for Dec. 31, 2012NuPathe Historical Book Value Per Share Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -0.2118 |
| Sept. 30, 2012 | -0.2826 |
| June 30, 2012 | 0.0868 |
| March 31, 2012 | 0.4758 |
| Dec. 31, 2011 | 0.8795 |
| Sept. 30, 2011 | 1.230 |
| June 30, 2011 | 1.708 |
| March 31, 2011 | 2.116 |
| Dec. 31, 2010 | 2.355 |
| Sept. 30, 2010 | 2.766 |
About Book Value per Share
Book value per share indicates the book value (or accounting value) of each share of stock. Book value is a company's net asset value, which is calculated by total assets minus intangible assets and liabilities. A relatively high book value per share in relation to stock price often occurs when a stock is undervalued.
In the rare circumstance that market price falls below the book value per share, generally a stock is undervalued and might be an attractive buy.
Learn More
PATH Book Value Per Share Benchmarks
| Companies | |
|---|---|
| Cadence Pharmaceuticals | 0.5612 |
| Cytori Therapeutics | 0.0961 |
| ARCA biopharma | 1.039 |
PATH Book Value Per Share Range, Past 5 Years
| Minimum | -0.2826 | Sep 2012 |
| Maximum | 2.766 | Sep 2010 |
| Average | 1.112 |